A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio
نویسندگان
چکیده
منابع مشابه
A potential marker of bare metal stent restenosis: monocyte count - to- HDL cholesterol ratio
BACKGROUND Oxidation and inflammation play significant roles in the pathogenesis of coronary artery diseases. Monocyte count to high-density lipoprotein (HDL) cholesterol ratio (MHR) is a new marker and has revealed as an indicator of inflammation in the literature. The present study aimed to search the effect of MHR on in-stent restenosis (ISR) in patients with stable or unstable angina pector...
متن کاملVery Late Restenosis of a Paclitaxel- Eluting Stent Implanted to Treat Previous in-Stent Restenosis of a Bare Metal Stent
Mechanical alternans refers to the succession of strong and weak heartbeats. It is classically associated with advanced-stage heart failure although it can also be seen in aortic stenosis, hypertrophic cardiomyopathy, a sharp increase in cardio post load, a drop in preload, acute ischaemia and the onset of tachycardia. Mechanical alternans have been explained by mechanisms related to the FrankS...
متن کاملVery late restenosis of a paclitaxel-eluting stent implanted to treat previous in-stent restenosis of a bare metal stent.
Unlike what was observed with brachytherapy,1 the use of drug-eluting stents (DES) has not been associated with the delayed intimal proliferation that characterises restenosis. A 12-month followup is recommended to define the need for revascularisation in DES.2 Restenosis 1 year after the implant is considered unusual. We present the case of a 77-year-old hypertensive male ex-smoker with diabet...
متن کاملDrug-Eluting Balloons or Stents for Bare-Metal Stent Restenosis.
D rug-eluting stents (DES) represent the gold standard device for percutaneous coronary intervention (1). Nevertheless, bare-metal stents (BMS) are still used in patients at high bleeding risk or if immediate surgery is pending, to allow shorter dual-antiplatelet therapy duration in comparison with DES. Furthermore, economic restraints and limited availability of DES in some regions justify con...
متن کاملA randomized comparison of drug-eluting balloon versus everolimus-eluting stent in patients with bare-metal stent-in-stent restenosis: the RIBS V Clinical Trial (Restenosis Intra-stent of Bare Metal Stents: paclitaxel-eluting balloon vs. everolimus-eluting stent).
OBJECTIVES This study sought to compare the efficacy of drug-eluting balloons (DEB) with that of everolimus-eluting stents (EES) in patients with bare-metal stents (BMS) in-stent restenosis (ISR). BACKGROUND Treatment of patients with ISR remains a challenge. METHODS This was a prospective, multicenter, randomized trial comparing DEB with EES in patients with bare-metal stents (BMS) in-sten...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMC Cardiovascular Disorders
سال: 2016
ISSN: 1471-2261
DOI: 10.1186/s12872-016-0367-3